Community-acquired pneumonia as an emergency condition

Area of Science:

• Pulmonology
• Infectious Diseases
• Epidemiology

Background:

• Community-acquired pneumonia (CAP) presents a substantial global burden of disease, with high morbidity and mortality rates, especially in the elderly population.
• Despite advances in management, CAP continues to pose significant challenges to healthcare systems worldwide.

Purpose of the Study:

• This review synthesizes recent findings on the epidemiology, etiology, diagnosis, and management of community-acquired pneumonia.
• To provide an updated overview of the current landscape of CAP.

Main Methods:

• Literature review focusing on recent studies and evidence.
• Analysis of epidemiological trends, causative agents, diagnostic advancements, and therapeutic strategies for CAP.

Main Results:

• While overall CAP mortality has declined, pneumococcal CAP mortality remains unchanged over two decades, with increased hospitalization and severity.
• Streptococcus pneumoniae is the predominant cause, but molecular diagnostics reveal respiratory viruses are also common culprits.
• The emergence of multidrug-resistant pathogens is a growing global concern.

Conclusions:

• Prompt identification of CAP's causative agent is crucial for effective pathogen-directed antibiotic therapy and antimicrobial stewardship.
• Optimizing CAP management requires integrating recent knowledge into clinical practice, including vaccine strategies.
• Addressing the challenges of resistant pathogens and viral etiologies is essential for improving patient outcomes.